These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

247 related items for PubMed ID: 31382914

  • 1. Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study.
    Yang YZ, Chen P, Liu LJ, Cai QQ, Shi SF, Chen YQ, Lv JC, Zhang H.
    BMC Nephrol; 2019 Aug 05; 20(1):297. PubMed ID: 31382914
    [Abstract] [Full Text] [Related]

  • 2. Effect of hydroxychloroquine in patients with IgA nephropathy with insufficient responses to immunosuppressive therapy: a retrospective case-control study.
    Tang C, Lv JC, Shi SF, Chen YQ, Liu LJ, Zhang H.
    BMC Nephrol; 2020 Nov 10; 21(1):469. PubMed ID: 33172397
    [Abstract] [Full Text] [Related]

  • 3. Effects of Hydroxychloroquine on Proteinuria in Immunoglobulin A Nephropathy.
    Yang YZ, Liu LJ, Shi SF, Wang JW, Chen YQ, Lv JC, Zhang H.
    Am J Nephrol; 2018 Nov 10; 47(3):145-152. PubMed ID: 29502121
    [Abstract] [Full Text] [Related]

  • 4. Comparison between hydroxychloroquine and systemic corticosteroids in IgA nephropathy: a two-year follow-up study.
    Si FL, Tang C, Lv JC, Shi SF, Zhou XJ, Liu LJ, Zhang H.
    BMC Nephrol; 2023 Jun 15; 24(1):175. PubMed ID: 37322444
    [Abstract] [Full Text] [Related]

  • 5. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Randomized Controlled Trial.
    Liu LJ, Yang YZ, Shi SF, Bao YF, Yang C, Zhu SN, Sui GL, Chen YQ, Lv JC, Zhang H.
    Am J Kidney Dis; 2019 Jul 15; 74(1):15-22. PubMed ID: 30922594
    [Abstract] [Full Text] [Related]

  • 6. Hydroxychloroquine in IgA nephropathy: a systematic review.
    Stefan G, Mircescu G.
    Ren Fail; 2021 Dec 15; 43(1):1520-1527. PubMed ID: 34779707
    [Abstract] [Full Text] [Related]

  • 7. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis.
    Zhang J, Lu X, Feng J, Li H, Wang S.
    Biomed Res Int; 2021 Dec 15; 2021():9171715. PubMed ID: 34901280
    [Abstract] [Full Text] [Related]

  • 8. Hydroxychloroquine alleviates persistent proteinuria in IgA nephropathy.
    Gao R, Wu W, Wen Y, Li X.
    Int Urol Nephrol; 2017 Jul 15; 49(7):1233-1241. PubMed ID: 28349446
    [Abstract] [Full Text] [Related]

  • 9. Long-term safety and efficacy of hydroxychloroquine in patients with IgA nephropathy: a single-center experience.
    Tang C, Lv JC, Shi SF, Chen YQ, Liu LJ, Zhang H.
    J Nephrol; 2022 Mar 15; 35(2):429-440. PubMed ID: 33591553
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and Safety of Hydroxychloroquine in Patients with IgA Nephropathy: A Meta-Analysis.
    Zhang Z, Liu X, Ye P, Xie C, Kong Y.
    Arch Esp Urol; 2024 Jan 15; 77(1):16-24. PubMed ID: 38374008
    [Abstract] [Full Text] [Related]

  • 11. The efficacy and safety of hydroxychloroquine in pregnant patients with IgA nephropathy: A retrospective cohort study.
    Tang C, Si FL, Yao YX, Lv JC, Shi SF, Chen YQ, Liu LJ, Zhang H.
    Nephrology (Carlton); 2022 Feb 15; 27(2):155-161. PubMed ID: 34713949
    [Abstract] [Full Text] [Related]

  • 12. Hydroxychloroquine blood concentrations and effects in Chinese patients with IgA nephropathy.
    Yang T, Shi Y, Wang Y, Feng Y, Shao Q, Jiang C, Wang L, Liu J.
    J Nephrol; 2024 Jul 24. PubMed ID: 39048780
    [Abstract] [Full Text] [Related]

  • 13. Early reduction in total cholesterol to high-density lipoprotein cholesterol ratio predicts hydroxychloroquine efficacy in treating IgA nephropathy.
    Shi Y, Yang T, Feng Y, Li N, Shao Q, Jiang C, Liu J.
    Ren Fail; 2024 Dec 24; 46(2):2397046. PubMed ID: 39212237
    [Abstract] [Full Text] [Related]

  • 14. Hydroxychloroquine Induces Remission for IgA Nephropathy With Mild to Moderate Proteinuria: A Single-Centered Retrospective Analysis.
    Pan Y, Le J, Lan L, Wang Y, Liu G, Shen X, Ren P, Chen J, Han F.
    Cureus; 2024 Feb 24; 16(2):e53395. PubMed ID: 38314382
    [Abstract] [Full Text] [Related]

  • 15. The efficacy and safety of hydroxychloroquine versus leflunomide in patients with IgA nephropathy: a single-center experience.
    He WJ, Wang J, Liu N, Li GY, Zhu XW, Yao L, Liu LL.
    J Nephrol; 2024 May 24; 37(4):933-940. PubMed ID: 38225440
    [Abstract] [Full Text] [Related]

  • 16. Changes in Proteinuria and Side Effects of Corticosteroids Alone or in Combination with Azathioprine at Different Stages of IgA Nephropathy.
    Sarcina C, Tinelli C, Ferrario F, Pani A, De Silvestri A, Scaini P, Del Vecchio L, Alberghini E, Buzzi L, Baragetti I, Pozzi C.
    Clin J Am Soc Nephrol; 2016 Jun 06; 11(6):973-981. PubMed ID: 27129712
    [Abstract] [Full Text] [Related]

  • 17. The Effect of Hydroxychloroquine on Residual Proteinuria in Patients With Immunoglobulin A Nephropathy: A Retrospective Study Based on Propensity Score Matching.
    Liu M, Bian X, Wang L, Li G.
    Front Med (Lausanne); 2022 Jun 06; 9():922365. PubMed ID: 35872760
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of corticosteroids in immunoglobulin A nephropathy with less than 25% crescents.
    Chen J, Xu H, Peng Z, Lin L, Li C, Zhu X, Liu S.
    Clin Exp Nephrol; 2020 Jan 06; 24(1):73-81. PubMed ID: 31605314
    [Abstract] [Full Text] [Related]

  • 19. Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison.
    Ismail G, Obrişcă B, Jurubiţă R, Andronesi A, Sorohan B, Vornicu A, Sinescu I, Hârza M.
    Medicine (Baltimore); 2020 Jun 26; 99(26):e21000. PubMed ID: 32590815
    [Abstract] [Full Text] [Related]

  • 20. Corticosteroid in IgA nephropathy with moderate proteinuria: A retrospective cohort study.
    Wang Y, Yu J, Jiang Y, Li J, Yimamuyushan A, Xia X, Fan L, Huang F, Chen W, Liu Q.
    Nephrology (Carlton); 2024 May 26; 29(5):268-277. PubMed ID: 38186010
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.